William R. Miller, M.D.

Assistant Professor
Houston Methodist Research Institute
Houston, TX, United States

William R. Miller, M.D. is an Assistant Professor of Medicine with the Division of Infectious Diseases at Houston Methodist Hospital, Houston Methodist Academic Institute, and Weill Cornell Medical College. Dr. Miller is a member of the Center for Infectious Diseases at the Houston Methodist Research Institute, where his current research interests involve the clinical impact and mechanistic bases of antimicrobial resistance. Active projects include studying the multilayered cell membrane defense networks of Gram-positive pathogens using enterococci as model organisms, understanding the inoculum effect in severe methicillin-sensitive Staphylococcus aureus infections, and characterizing the molecular mechanisms of resistance of multidrug resistant Pseudomonas aeruginosa.

Disclosure(s): Merck: Grant/Research Support; UptoDate: Royalties

Presentation(s):

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT

• 313 - Genomic Features Associated with Non-susceptibility to Cefiderocol in Pseudomonas aeruginosa and Cross-resistance to Novel β-lactam/β-lactamase Inhibitors in the Prospective Observational Pseudomonas (POP) study

  Friday, October 18, 2024
  11:06 AM – 11:18 AM US PT